Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is... Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.16 | 3.25203252033 | 4.92 | 5.5019 | 4.87 | 59107 | 5.12328851 | CS |
| 4 | -1.6 | -23.9520958084 | 6.68 | 6.895 | 4.68 | 90523 | 5.7048884 | CS |
| 12 | -0.94 | -15.6146179402 | 6.02 | 7.06 | 4.68 | 85929 | 6.20693171 | CS |
| 26 | 0.36 | 7.62711864407 | 4.72 | 7.06 | 3.96 | 103947 | 5.70235983 | CS |
| 52 | -5.18 | -50.4873294347 | 10.26 | 10.29 | 3.96 | 108350 | 6.25250267 | CS |
| 156 | -1.18 | -18.8498402556 | 6.26 | 11.92 | 3.96 | 102758 | 7.84733475 | CS |
| 260 | -1.92 | -27.4285714286 | 7 | 11.92 | 3.8219 | 125323 | 7.46759843 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
